What is the current valuation of the China organoids market in 2024?

The market valuation was $117.6 Million in 2024. Read More

What is the projected market size for the China organoids market by 2035?

The market is projected to reach $1203.89 Million by 2035. Read More

What is the expected CAGR for the China organoids market from 2025 to 2035?

The expected CAGR during the forecast period 2025 - 2035 is 23.55%. Read More

Which application segment has the highest valuation in the China organoids market?

Regenerative Medicine has the highest valuation, ranging from $35.0 Million to $350.0 Million. Read More

What are the key types of organoids in the market and their valuations?

Lung Organoids lead with valuations from $42.6 Million to $453.89 Million. Read More

Who are the major players in the China organoids market?

Key players include Organovo Holdings Inc, TissUse GmbH, and Mimetas B.V. Read More

What is the valuation range for the Drug Discovery application segment?

The valuation range for Drug Discovery is from $30.0 Million to $300.0 Million. Read More

Which end user segment shows the highest market potential?

Pharmaceutical Companies show the highest potential, with valuations from $35.28 Million to $353.56 Million. Read More

What sources are utilized in the China organoids market?

The market utilizes sources such as Human Tissue, Animal Tissue, and Stem Cells. Read More

How does the market for Brain Organoids compare to other types?

Brain Organoids have a valuation range of $20.0 Million to $200.0 Million, which is lower than Lung and Intestinal Organoids. Read More

China Organoids Market

ID: MRFR/HC/43370-HCR 200 Pages Vikita Thakur Last Updated: September 17, 2026

China Organoids Market Research Report By Product (Product, Service), By Type of organoids (Liver, Kidney, Pancreas, Intestine, Others), By Application (Drug Testing, Developmental Biology, Personalized Medicine, Regenerative Medicine, Others) and By End-user (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Others) -Forecast to 2035

China Organoids Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)23.55%

2024 Market Size$ 117.6 Million

2025 Market Size$ 145.29 Million

2035 Market Size$ 1,203.89 Million

Key Players

Organovo Holdings Inc

TissUse GmbH

Mimetas B.V.

InSphero AG

StemoniX Inc

Hesperos Inc

Trends

Rising Demand for Personalized Medicine
Advancements in Research and Development
Government Support and Regulatory Framework

Opportunities

Rising Prevalence of Chronic Diseases
Growing Focus on Regenerative Medicine
Increasing Investment in Biotechnology

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Application (USD Million)
  1. 4.1.1 Drug Discovery
  2. 4.1.2 Disease Modeling
  3. 4.1.3 Regenerative Medicine
  4. 4.1.4 Toxicity Testing
2. 4.2 Life Sciences, BY Type (USD Million)
  1. 4.2.1 Intestinal Organoids
  2. 4.2.2 Liver Organoids
  3. 4.2.3 Brain Organoids
  4. 4.2.4 Lung Organoids
3. 4.3 Life Sciences, BY End User (USD Million)
  1. 4.3.1 Pharmaceutical Companies
  2. 4.3.2 Research Institutions
  3. 4.3.3 Academic Institutions
  4. 4.3.4 Biotechnology Companies
4. 4.4 Life Sciences, BY Source (USD Million)
  1. 4.4.1 Human Tissue
  2. 4.4.2 Animal Tissue
  3. 4.4.3 Stem Cells
  4. 4.4.4 Induced Pluripotent Stem Cells
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Organovo Holdings Inc (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 TissUse GmbH (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Mimetas B.V. (NL)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 InSphero AG (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 StemoniX Inc (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Hesperos Inc (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 CN Bio Innovations Ltd (GB)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Reprocell Inc (JP)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 CHINA MARKET ANALYSIS BY APPLICATION
3. 6.3 CHINA MARKET ANALYSIS BY TYPE
4. 6.4 CHINA MARKET ANALYSIS BY END USER
5. 6.5 CHINA MARKET ANALYSIS BY SOURCE
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY TYPE, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY SOURCE, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY SOURCE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY SOURCE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Enquiry

Customize Report

China Life Sciences Market Segmentation

Life Sciences By Application (USD Million, 2025-2035)

Drug Discovery
Disease Modeling
Regenerative Medicine
Toxicity Testing

Life Sciences By Type (USD Million, 2025-2035)

Intestinal Organoids
Liver Organoids
Brain Organoids
Lung Organoids

Life Sciences By End User (USD Million, 2025-2035)

China Organoids Market Companies
Research Institutions
Academic Institutions
Biotechnology Companies

Life Sciences By Source (USD Million, 2025-2035)

Human Tissue
Animal Tissue
Stem Cells
Induced Pluripotent Stem Cells

Certified Researchers

Enquiry

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”